Skip to main navigation Skip to search Skip to main content

How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)648
Number of pages1
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume3
Issue number4
DOIs
StatePublished - 2015

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this